skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon
The clinical trial landscape continues to evolve as scientific breakthroughs and technological innovations emerge. Examine the state of Phase I–III clinical trials initiated in 2019 when you download the Annual Clinical Trials Roundup from Citeline’s Trialtrove, your trusted source for global clinical trials intelligence.



Download this whitepaper >

This comprehensive analysis looks at the competitive trial landscape:

  • The innovations to watch, and the companies making them happen
  • The shifts in drug development priorities and strategies you should know about
  • How the new leading sponsors and collaborators view the industry’s evolution
  • A geographical survey of trial activity and trends in key global markets
  • Metrics by therapeutic area, trial phase, and disease
Clinical Trials 2019 Round Up Whitepaper

Get this infographic >

While 2020 has unfolded into a year unlike any other, how did the clinical trial activity in 2019 set the stage?

Through Trialtrove’s annual analysis of Phase I–III clinical trials that initiated in the previous year, initial insights into the overall biopharma industry’s activities are reviewed, providing a glimpse of how the landscape fared before it shifted dramatically.

Clinical Trials 2019 Round Up Infographic